RGNX Latest Press Releases

-- August 25, 2026 --

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX) Business Wire 12:53 PM

REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli PRNewswire 7:05 AM

-- August 24, 2026 --

RGNX Investor Notice: Johnson Fistel Investigates REGENXBIO Inc. Following Clinical Hold Globe Newswire 2:18 PM

REGENXBIO Announces Regulatory Update on RGX-121 for MPS II PRNewswire 7:06 AM

-- August 6, 2026 --

REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights PRNewswire 7:05 AM

-- August 3, 2026 --

REGENXBIO to Host Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Operational Highlights PRNewswire 7:05 AM

-- July 21, 2026 --

Kuehn Law Encourages Investors of Regenxbio, Inc. to Contact Law Firm PRNewswire 7:29 PM

-- July 18, 2026 --

REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting PRNewswire 2:55 PM

-- July 17, 2026 --

REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants PRNewswire 7:00 AM

-- July 16, 2026 --

REGENXBIO Announces Proposed Public Offering of Common Stock PRNewswire 4:27 PM

-- July 13, 2026 --

Kuehn Law Encourages Investors of Regenxbio, Inc. to Contact Law Firm Globe Newswire 3:32 PM

-- June 29, 2026 --

REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone PRNewswire 7:05 AM

-- June 24, 2026 --

REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026 PRNewswire 7:05 AM

-- June 22, 2026 --

REGENXBIO Announces Alignment with FDA on Path Forward for NAVSUNLI BLA Resubmission for Accelerated Approval; First Potential Gene Therapy for MPS II PRNewswire 7:30 AM

-- May 18, 2026 --

REGENXBIO to Participate in Upcoming Investor Conferences PRNewswire 4:05 PM

-- May 14, 2026 --

REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights PRNewswire 7:10 AM

REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE Study of RGX-202 PRNewswire 7:00 AM

-- May 7, 2026 --

REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting PRNewswire 7:05 AM

-- May 6, 2026 --

REGENXBIO to Host Webcast on May 14 to Discuss Topline Results from Pivotal Trial of RGX-202 for Duchenne Muscular Dystrophy PRNewswire 5:24 PM

-- April 14, 2026 --

REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX PRNewswire 8:05 PM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX Globe Newswire 3:51 PM

RGNX Deadline Today: RGRX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit PRNewswire 2:00 PM

RGNX Deadline Today: Rosen Law Firm Urges REGENXBIO, Inc. (NASDAQ: RGNX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Business Wire 11:45 AM

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of the Securities Class Action Lawsuit Deadline on April 14, 2026 Business Wire 9:34 AM

Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors Globe Newswire 9:00 AM

RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit -- The Gross Law Firm PRNewswire 9:00 AM

-- April 13, 2026 --

REGENXBIO DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - RGNX Newsfile 4:13 PM

-- April 12, 2026 --

REGENXBIO DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages REGENXBIO, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - RGNX Globe Newswire 11:14 AM

-- April 11, 2026 --

REGENXBIO DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages REGENXBIO, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - RGNX Newsfile 11:18 PM

-- April 10, 2026 --

RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit - The Gross Law Firm Globe Newswire 11:47 AM

RGNX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 PRNewswire 11:23 AM

-- April 9, 2026 --

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Globe Newswire 3:09 PM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX PRNewswire 10:01 AM

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Kyndryl Holdings, Inc. (KD), uniQure N.V. (QURE), and REGENXBIO Inc. (RGNX) Announced by Holzer & Holzer, LLC Globe Newswire 8:00 AM

-- April 7, 2026 --

ROSEN, A TOP RANKED LAW FIRM, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 10:47 PM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX Globe Newswire 3:44 PM

RGNX Shareholder Alert: April 14, 2026 Lead Plaintiff Deadline in REGENXBIO Inc. Securities Class Action Lawsuit -- The Gross Law Firm PRNewswire 9:02 AM

-- April 6, 2026 --

Levi & Korsinsky, LLP: RGNX Disclosure Timeline Reveals Pattern of Alleged Investor Harm Globe Newswire 4:00 PM

ROSEN, SKILLED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 3:48 PM

RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 4:04 AM

-- April 5, 2026 --

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Globe Newswire 7:52 PM

-- April 4, 2026 --

ROSEN, SKILLED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Globe Newswire 9:12 PM

RGNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 PRNewswire 7:56 AM

-- April 3, 2026 --

REGENXBIO, Inc. Class Action Reminder - Robbins LLP Encourages RGNX Stockholders to Contact the Firm for Information About Their Rights PRNewswire 3:19 PM

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PayPal and REGENXBIO and Encourages Investors to Contact the Firm Globe Newswire 2:03 PM

-- April 2, 2026 --

ROSEN, A NATIONALLY RECOGNIZED INVESTOR RIGHTS LAW FIRM, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 8:04 PM

RGNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 Globe Newswire 10:30 AM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX PRNewswire 10:00 AM

-- April 1, 2026 --

ROSEN, A TOP RANKED INVESTOR RIGHTS LAW FIRM, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 8:16 PM

ROSEN, A TOP RANKED INVESTOR RIGHTS LAW FIRM, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Globe Newswire 4:53 PM

-- March 31, 2026 --

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 8:11 PM

RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit -- The Gross Law Firm PRNewswire 9:01 AM

Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors Globe Newswire 9:00 AM

-- March 30, 2026 --

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 8:06 PM

LEVI & KORSINSKY, LLP: RGNX DISCLOSURE TIMELINE REVEALS PATTERN OF ALLEGED INVESTOR HARM Globe Newswire 4:00 PM

REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX PRNewswire 4:06 AM

RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 4:02 AM